Waters Co. (WAT) Expected to Announce Quarterly Sales of $670.98 Million

Equities research analysts expect Waters Co. (NYSE:WAT) to announce sales of $670.98 million for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for Waters’ earnings, with estimates ranging from $663.20 million to $673.00 million. Waters reported sales of $628.79 million during the same quarter last year, which indicates a positive year over year growth rate of 6.7%. The firm is expected to report its next quarterly earnings results before the market opens on Tuesday, January 23rd.

According to Zacks, analysts expect that Waters will report full-year sales of $670.98 million for the current financial year, with estimates ranging from $2.29 billion to $2.30 billion. For the next year, analysts expect that the business will post sales of $2.43 billion per share, with estimates ranging from $2.40 billion to $2.45 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow Waters.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million during the quarter, compared to analyst estimates of $555.25 million. Waters had a net margin of 24.34% and a return on equity of 23.61%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.57 earnings per share.

Several research firms recently weighed in on WAT. Zacks Investment Research lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Saturday, January 6th. Barclays restated a “hold” rating and set a $202.00 price target on shares of Waters in a research report on Monday, January 8th. BTIG Research began coverage on shares of Waters in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price target for the company. Morgan Stanley upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target for the company in a research report on Monday, December 4th. Finally, Cowen restated a “hold” rating and set a $190.00 price target on shares of Waters in a research report on Friday, November 3rd. Eleven research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Waters presently has an average rating of “Hold” and an average price target of $197.33.

In other Waters news, Director Joann A. Reed sold 1,386 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total transaction of $268,981.02. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Rohit Khanna sold 26,913 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the sale, the senior vice president now directly owns 13,677 shares in the company, valued at $2,707,088.61. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 93,159 shares of company stock worth $18,412,172. Insiders own 5.07% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in WAT. Janus Henderson Group PLC lifted its holdings in Waters by 20,670.6% during the second quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock valued at $354,773,000 after purchasing an additional 1,920,502 shares during the last quarter. Harding Loevner LP lifted its holdings in shares of Waters by 207.1% in the third quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock worth $158,275,000 after buying an additional 1,866,848 shares in the last quarter. Koch Industries Inc. lifted its holdings in shares of Waters by 36,932.0% in the second quarter. Koch Industries Inc. now owns 534,742 shares of the medical instruments supplier’s stock worth $532,000 after buying an additional 533,298 shares in the last quarter. Fundsmith LLP lifted its holdings in shares of Waters by 11.7% in the second quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after buying an additional 401,420 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of Waters by 157.5% in the third quarter. Mackenzie Financial Corp now owns 651,400 shares of the medical instruments supplier’s stock worth $116,939,000 after buying an additional 398,438 shares in the last quarter. 92.13% of the stock is currently owned by institutional investors and hedge funds.

Waters (NYSE WAT) opened at $209.16 on Thursday. The firm has a market cap of $16,617.63, a PE ratio of 30.85, a P/E/G ratio of 2.80 and a beta of 0.82. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. Waters has a 1 year low of $137.72 and a 1 year high of $211.65.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3143929/waters-co-wat-expected-to-announce-quarterly-sales-of-670-98-million.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Get a free copy of the Zacks research report on Waters (WAT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.